Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Functional Proteomic Profiling of Triple-Negative Breast Cancer

15 Oct 2021

Abstract excerpt

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that comprises various disease entities, all of which share a set of common features: a lack of expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, respectively. Because of their receptor status, conventional chemotherapy remains the main therapeutic option for TNBC patients. We employed a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Breast Cancer Treatment Studies
Share to Cancer Cells and Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34685748
DOI: 10.3390/cells10102768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Functional Proteomic Profiling of Triple-Negative Breast CancerPMID 34685748Read ↗

The Proteomic Landscape of Triple-Negative Breast CancerSemantic proximity Read ↗

Quantitative proteomics analysis of triple-negative breast cancersSemantic proximity Read ↗

Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancerSemantic proximity Read ↗

Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomicsSemantic proximity Read ↗

Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancerSemantic proximity Read ↗

Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.Semantic proximity Read ↗

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.Semantic proximity Read ↗

Functional proteomics outlines the complexity of breast cancer molecular subtypes.Semantic proximity Read ↗

Proteogenomic Characterization of Triple-Negative Apocrine Carcinoma Reveals Molecular Features of Progression and Chemotherapy ResponseSemantic proximity Read ↗

Multiomic profiling of metastatic potential in estrogen receptor-positive human epidermal growth factor-negative breast cancerSemantic proximity Read ↗

Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cellsSemantic proximity Read ↗

Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.